03.01.2015 Views

September - APNA

September - APNA

September - APNA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PROFESSIONAL ISSUES<br />

Member questions – continued<br />

• 01/07/2012: 23%<br />

• 01/07/2013: 24%<br />

• 01/07/2010: 25%<br />

You can contact the ANF for further advice on<br />

pay and conditions.<br />

I have a keen interest in Well Women’s Health<br />

and, more specifically, incontinence. I have been<br />

furthering my education in this field by completing<br />

the Benchmarque course in Continence<br />

Management and a Pauline Chiarelli Workshop.<br />

As a result, I feel confident in promoting,<br />

discussing and educating women on this health<br />

condition. The practice GPs refer women to me<br />

for consultation. The issue is what do we ‘bill’<br />

them to still be ‘legal’ How can we work it out<br />

so it is of benefit to everyone<br />

This is exactly the issue we have been arguing<br />

for in the restriction of the current MBS PN<br />

item numbers. The only way you can ‘bill’ for<br />

incontinence services is by including the GP in<br />

the consult so that he/she can bill through a<br />

normal GP consult or you can privately bill for<br />

this service — which is uncommon, but quite<br />

OK (frequently done in New Zealand).<br />

The intention of the new PN funding incentive<br />

coming in 2012 is to allow a flexible funding<br />

model through which nurses can provide a range<br />

of clinical services without having to involve GPs<br />

for the purpose of billing. There is a high degree<br />

of opposition to this model of funding from the<br />

GPs and there will be a lot of working out to do<br />

in its implementation.<br />

You must not get ‘legal’ and ‘billing’ confused.<br />

You are legally able to provide the care in which<br />

you have been trained and are competent to do.<br />

Whether it can be funded is a different matter —<br />

the ‘for and on behalf of’ type of language in the<br />

MBS is not a legal ruling for the GPs.<br />

As a PN, I can see a huge advantage in the removal<br />

of ‘task based’ item numbers. Unfortunately, the<br />

majority of GPs only see the bottom line. Our GPs<br />

have already starting talking about reducing<br />

nursing hours as this has also come at the same<br />

time as when they are getting significantly less<br />

income due to the changes in health assessment<br />

funding. Are larger practices going to be<br />

disadvantaged financially from the proposed<br />

changes<br />

Larger practices are potentially going be<br />

disadvantaged under the new proposal due to<br />

the capping at 5 EFT GPs. However, we will have<br />

the opportunity to argue for increasing the cap<br />

through the advisory group process and both the<br />

medical and nursing groups agree on this point.<br />

In addition there is a commitment that if the<br />

practice can demonstrate that it will be<br />

disadvantaged under the new system, it can be<br />

grandfathered into the scheme over three years.<br />

This would provide plenty of time to assess the<br />

operational benefits and disadvantages. GPs who<br />

currently receive a percentage of the PN item<br />

numbers as income (contractor or employee GPs)<br />

will have a reduction in income. However, if the<br />

overall income to the practice is increased, the<br />

practice can revisit their contracts with those GPs<br />

and amend these to ensure no loss of income.<br />

There will be grandfathering arrangements for<br />

the first three years of the program to ensure<br />

that practices are not adversely impacted by the<br />

restructure of the Practice Incentive Program<br />

practice nurse incentive and the MBS practice<br />

nurse items.<br />

alginate gel with enzymes that kill absorbed bacteria 1<br />

Advanced technology wound care with 3 clinical benefits<br />

• Moist wound environment • Continuous auto-debridement • Broad spectrum anti-bacterial activity 1<br />

Grade 2 leg skin tear treated with Flaminal ® Hydro 2<br />

Day 0 Day 30<br />

Day 68<br />

www.flaminalaustralia.com<br />

alginate gel with enzymes that<br />

kill absorbed bacteria 1<br />

[1] White R. ‘Flaminal: A novel approach to wound bioburden control’, Wounds UK 2006, 2 (3): 64–69. [2] Data on file at Flen Pharma. FD10019<br />

4<br />

Flen Pharma NV<br />

Aspen Pharmacare Australia Pty Limited<br />

Blauwesteenstraat 87, B-2550 Kontich, Belgium<br />

ABN 51 096 236 985<br />

www.flenpharma.com<br />

34–36 Chandos Street, St Leonards NSW 2065<br />

Primary Times <strong>September</strong> 2010 ® : Trademark of Flen Pharma Ph +61 2 8436 8300 ■ www.aspenpharma.com.au

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!